Key clinical point: Screening for marijuana use is lacking in inflammatory bowel disease.
Major finding: Fewer than 5% of charts of IBD patients noted marijuana use.
Study details: Chart review of 381 records at a university GI clinic during a 5-year period.
Disclosures: Mr. Baumgartner had no financial relationships to disclose.
Baumgartner S et al. Crohn’s & Colitis Congress 2020. 2020 Jan 23. Poster 011.